pharmaceuticals

Global Custom Market Research Reports Provider Company

phone

Virbac Group (VIRP) - Financial and Strategic SWOT Analysis Review

  • Published Date: 11 Apr 2018
  • Number of Pages: 35
  • Category: Pharmaceuticals
  • Country: France
Virbac Group (VIRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Virbac Group (Virbac) is an animal health company that develops and produces vaccines and medicines for domestic animals and livestock. It manufactures pet medications such as vaccines, antibiotics, pest control drugs, mouth/dental care products, anesthetics, anti-inflammatory drugs and dermatological products for horses, dogs, cats and livestock. Virbacs products include ear cleanser for dogs and cats; food supplement for cattle; tablets for the prevention of canine heartworm disease and treatment of roundworms and hookworms; general anesthetics and others. The company has manufacturing, research and development, and operational subsidiaries across Europe, North America, Asia-Pacific, Latin America, Africa and the Middle East. Virbac is headquartered in Carros, France.

Virbac Group Key Recent Developments

Jun 23,2017: Virbac appoints Sbastien Huron as chairman of executive board
Apr 21,2017: Veterinary Pharma firm Virbac to consolidate warehousing and distribution to new facility in Kansas, will create ne jobs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData

3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Virbac Group - Key Facts 6
Virbac Group - Key Employees 7
Virbac Group - Key Employee Biographies 8
Virbac Group - Major Products and Services 9
Virbac Group - History 10
Virbac Group - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 Company Analysis 15
Company Overview 15
Virbac Group - Business Description 15
Business Segment: Companion Animals Segment 15
Overview 15
Performance 15
Business Segment: Other Segment 15
Performance 15
Business Segment: The Food Producing Animals Segment 15
Overview 15
Performance 16
Geographical Segment: Africa & Middle East 16
Performance 16
Geographical Segment: Asia 16
Performance 16
Geographical Segment: Europe (excluding France) 16
Performance 16
Geographical Segment: France 16
Performance 16
Geographical Segment: Latin America 16
Performance 16
Geographical Segment: North America 16
Performance 16
Geographical Segment: Other Segment 16
Overview 16
Geographical Segment: Pacific 17
Performance 17
Virbac Group - Corporate Strategy 18
Virbac Group - SWOT Analysis 19
SWOT Analysis - Overview 19
Virbac Group - Strengths 19
Virbac Group - Weaknesses 20
Virbac Group - Opportunities 21
Virbac Group - Threats 22
Virbac Group - Key Competitors 23
Section 3 Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios - Interim Ratios 29
Financial Ratios - Ratio Charts 30
Section 4 Appendix 31
Methodology 31
Ratio Definitions 31
About GlobalData 35
Contact Us 35
Disclaimer 35

List Of Tables

List of Tables
Virbac Group, Key Facts 6
Virbac Group, Key Employees 7
Virbac Group, Key Employee Biographies 8
Virbac Group, Major Products and Services 9
Virbac Group, History 10
Virbac Group, Subsidiaries 12
Virbac Group, Key Competitors 23
Virbac Group, Ratios based on current share price 24
Virbac Group, Annual Ratios 25
Virbac Group, Annual Ratios (Cont...1) 26
Virbac Group, Annual Ratios (Cont...2) 27
Virbac Group, Interim Ratios 29
Currency Codes 31
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 32
Cost Ratios 33
Liquidity Ratios 33
Leverage Ratios 34
Efficiency Ratios 34

List Of Figures

List of Figures
Virbac Group, Performance Chart (2013 - 2017) 28
Virbac Group, Ratio Charts 30

Virbac Group (VIRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports